Trial intelligence / Profile preview

FLUADE DCM trial: flutamide for androgen-dependent familial dilated cardiomyopathy

jRCTs051180123Active, not recruiting

Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of flutamide in dilated cardiomyopathy (DCM). Primary endpoint: Change in plasma BNP levels. Started Jan 2013; status: active, not recruiting.

02

Drugs

flutamide
03

Conditions

dilated cardiomyopathy (DCM)

Beyond the preview

Go deeper on jRCTs051180123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051180123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call